Format innovation forces Usana Health Sciences to rethink product, packaging, and DTC strategy

Format innovation forces rethink of Usana’s product strategy

Usana Health Sciences faces mounting pressure from rapid format innovation in the functional food and beverage market as companies push measured‑dose and portable delivery systems beyond traditional supplements. Doseology Sciences this week begins pilot production of nicotine‑free, caffeine‑based oral pouches that mirror the convenience and dosing control consumers already accept in nicotine pouches, underscoring a broader move toward single‑serve, on‑the‑go formats. For Usana, known for vitamins, supplements and direct‑selling distribution, these shifts increase the need to reassess packaging, dosing technology and go‑to‑consumer channels to retain relevance with younger, convenience‑driven buyers.

The trend highlights both a challenge and an opportunity for Usana’s R&D and marketing functions. Measured‑dose pouches and functional beverages require reformulation for clean‑label positioning, different stability and delivery science, and new compliance checks — areas where Usana’s existing clinical and manufacturing experience can be leveraged but will require targeted investment. Direct‑to‑consumer testing and rapid pilot runs, as Doseology is pursuing, create a faster feedback loop than traditional multilevel marketing rollouts, prompting established players such as Usana to speed product iteration and expand digital consumer insights to match market responsiveness.

Strategically, Usana can pursue multiple responses without abandoning its core business: accelerate internal development of novel delivery formats, form partnerships with boutique functional brands, or pilot limited DTC releases to validate demand for pouches and beverages. Industry momentum toward nootropics, sugar‑ and carbonation‑free formulations, and measured dosing favors companies that blend clinical credibility with format innovation; Usana’s brand recognition gives it an entry point if it adapts packaging, supply chain and promotional models to new consumption occasions.

Doseology’s pilot, acquisition and advisor hire

Doseology’s pilot program stems from its August acquisition of Feed That Brain, a Toronto cognitive‑health label, and starts with direct‑to‑consumer testing of sugar‑ and carbonation‑free caffeine pouches under the Feed That Brain brand. President and COO Tim Corkum describes the move as a disciplined approach to evaluate formats and capture format‑innovation value in 2026.

Market backdrop and competitive set

Industry analysts project the global functional food and beverage market reaches about $438 billion by 2026 and the modern oral segment tops $25 billion by 2030, with functional beverages near $164 billion this year. Retail veteran Joseph Mimran joins Doseology as a strategic advisor under a three‑year restricted share‑unit agreement as the company pursues branding and retail execution.